Hester Biosciences inks pact with IIT to develop vaccine against COVID-19

29 Apr 2020 Evaluate
Indian Institute of Technology (IIT) Guwahati is collaborating with Hester Biosciences to work on the vaccine development against COVID-19. The agreement between the two parties was signed on April 15, 2020.

The vaccine will be based on recombinant avian paramyxovirus based vector platform. The recombinant avian paramyxovirus-1 will be used to express the immunogenic protein of SARS-CoV-2. The recombinant avian paramyxovirus 1 expressing the SARS-CoV-2 protein could be used as a vaccine candidate for further study.

Hester Biosciences is engaged in the manufacturing of poultry vaccines.

Hester Biosciences Share Price

1482.80 45.90 (3.19%)
30-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1218.40
Cipla 1323.95
Zydus Lifesciences 885.20
Lupin 2151.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×